We previously demonstrated that in breast cancer, melanoma cell adhesion molecule (MCAM or CD146) may serve as an alternative marker that is expressed in EpCAM-negative cells [18], and that a modification in the CellSearch CTC enumeration kit can be used to detect MCAM-positive CTCs in breast cancer patients [19]. This evidence concerns the gene EPCAM and breast carcinoma.